LINC00649 and cancer: Although emerging data suggested that targeting LncRNAs was effective to hamper cancer progression and improve drug-resistance in GC, and multiple LncRNAs had been identified as diagnostic, therapeutic and prognostic biomarkers for GC, the involvement of a novel LncRNA LINC00649 in regulating GC pathogenesis had not been studied.